One Biology and Diagnosis.- 1. Pathology of brain tumors and its clinicobiological correlates.- 2. Immunohistochemistry in brain tumor classification.- 3. Molecular biological events in the selection of chemotherapy resistant-cells in human malignant gliomas.- 4. Expression of multiple activated cellular oncogenes in human brain tumors.- 5. Proliferative potential of astrocytomas and glioblastomas.- 6. The biological relevance of Arachidonic Acid Metabolism in human brain tumors.- 7. Computed tomography and magnetic resonance in the diagnosis of brain tumors.- 8. The application of positron emission tomography in studies of human cerebral glioma.- 9. Angiography in brain tumours.- 10. Stereotactic approach in brain tumors.- 11. Cellular localization of glucocorticoid receptor mRNAs in human CNS tumors by in situ hybridization.- 12. Proto-oncogene expression and proliferative activity in human malignant gliomas.- 13. Coexpression of PDGF and PDGF-receptors genes in human astrocytic gliomas.- 14. Diagnostic and prognostic significance of positron emission tomography in gliomas.- 15. Brain haemodynamics in intracranial supratentorial tumors.- 16. The glycosphingolipids of human astrocytomas.- 17. Findings of aberrant epidermal growth factor receptor in primary human malignant gliomas.- 18. Expression of epidermal growth factor receptor (EGF-R) and Erb-B2 (HER 2/NEU) in glioblastoma (GBM): prognostic relevance.- 19. Evaluation of the proliferative potential of gliomas by KI 67 immunolabelling of stereotactic biopsy samples.- 20. Immunobiology of visualizable brain tumor cells: gamma interferon induces changes in the immune environment in each compartment of brain tumor spread.- 21. Epidemiology of primary cerebral tumors. Results of a multi-center study in the Veneto region of northern Italy.- 22. Simvastatin, a blocker of cholesterol biosynthesis inhibits human glioma cell profileration.- Two Therapy of Gliomas.- 23. Surgery of cerebral gliomas: state of the art.- 24. Advances in neuro-oncology for adult patients with supratentorial gliomas: from the window of radiation oncology.- 25. Recent clinical results in the chemotherapy of brain tumors: BTCG studies.- 26. Clinical application of radiolabeled human X human monoclonal antibody with interferon in the treatment of malignant glioma - preliminary report.- 27. Targeted therapy for CNS tumours with monoclonal antibodies (MAbs).- 28. Early or late surgery for supratentorial gliomas? A randomized study.- 29. Reoperation in the treatment of recurrent intracranial malignant astrocytomas.- 30. Symptomatic subependymoma: a clinico-pathologic and flow cytometric study.- 31. Prognostic factors in anaplastic astrocytomas after surgery and conventional radiotherapy.- 32. Intraoperative radiation therapy (IORT) for cerebral glioblastoma.- 33. Positron emission tomography (PET) applied to stereotactic interstitial brain brachytherapy for malignant glioma patients.- 34. Radiosensitization of human glioma cells by buthionine sulfoximine-induced glutathione depletion.- 35. Degenerative effects of the radiotherapy on the cerebral gliomas.- 36. High dose ACNU chemotherapy with autologous bone marrow transplantation for human malignant brain tumors.- 37. Intrathecal perfusion therapy with nitrosoureas against subarachnoid dissemination of glioma: experimental and clinical studies.- 38. The potential role of lonidamine in the combined treatment of malignant gliomas. A randomized study.- 39. Rabbit brain concentrations of doxorubicin during intraarterial infusions.- 40. 8-chloro-cyclic adenosine monophosphate is a potent inhibitor of human glioma cell proliferation in vitro.- 41. Radiosensitization with carotid arterial infusion of bromodeoxyuridine (BUdR) ± 5 fluorouracil (5FU) biomodulation with focal external beam radiation (FEBT) for malignant gliomas.- 42. Interstitial chemotherapy with drug impregnated polymer implants to treat brain tumors: pre-clinical and clinical studies.- 43. Biologic re

Specificaties